Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0UX4A
|
||||
Former ID |
DIB001674
|
||||
Drug Name |
HU-433
|
||||
Synonyms |
CB2 activator (osteoporosis); HU-433; CB2 activator (osteoporosis), Yissum
|
||||
Indication | Osteoporosis [ICD9: 733.0, V07.4; ICD10:M80-M81, Z79.890] | Investigative | [543878] | ||
Company |
Yissum Research Development Co
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(c(cc(cc1OC)C(CCCCCC)(C)C)OC)[C@@H]1C=C([C@H]2C(C)(C)<br />[C@@H]1C2)CO
|
||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Activator | [543878] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.